Cargando…
Embolisation Using Microvascular Plugs for Peripheral Applications: Technical Results and Mid-Term Outcomes
The Micro Vascular Plug(®) (MVP, Medtronic) is a mechanical embolic agent available in small sizes that allows for distal embolisation. The objective of this retrospective observational single-centre study was to assess MVP embolisation procedures performed at a university hospital. The 33 patients...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10452264/ https://www.ncbi.nlm.nih.gov/pubmed/37626671 http://dx.doi.org/10.3390/biomedicines11082172 |
_version_ | 1785095625968189440 |
---|---|
author | Mailli, Rémy Chevallier, Olivier Mazit, Amin Malakhia, Alexandre Falvo, Nicolas Loffroy, Romaric |
author_facet | Mailli, Rémy Chevallier, Olivier Mazit, Amin Malakhia, Alexandre Falvo, Nicolas Loffroy, Romaric |
author_sort | Mailli, Rémy |
collection | PubMed |
description | The Micro Vascular Plug(®) (MVP, Medtronic) is a mechanical embolic agent available in small sizes that allows for distal embolisation. The objective of this retrospective observational single-centre study was to assess MVP embolisation procedures performed at a university hospital. The 33 patients who underwent MVP embolisation in 2021 were included (mean age, 64; 24 males and 9 females). The primary endpoint was technical success, which was defined as a full first-attempt occlusion with one or more MVPs, as documented on the end-of-procedure angiogram. In all patients, 51 MVPs were used overall, with other embolic agents in 23 of the 33 cases (usually coils and/or glue); 22 of the 33 procedures were emergent for bleeding and 11 were planned for other indications. Of the three technical failures, two were due to an angled target artery configuration precluding microcatheterisation and one to failure of the device to release from its wire. The technical success rate was thus 90.9%. No patient experienced MVP migration or other major complications. Five patients had recurrent clinical symptoms; in four cases, the cause was collateral development, and in one case, the cause was incomplete initial embolisation. No instances of recanalisation were documented during the short follow-up of 12 months, for a 100% secondary clinical success rate. At our tertiary-level centre, the MVP was both effective and safe for peripheral applications. Interventional radiologists should be conversant with the techniques and indications of MVP embolisation. |
format | Online Article Text |
id | pubmed-10452264 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-104522642023-08-26 Embolisation Using Microvascular Plugs for Peripheral Applications: Technical Results and Mid-Term Outcomes Mailli, Rémy Chevallier, Olivier Mazit, Amin Malakhia, Alexandre Falvo, Nicolas Loffroy, Romaric Biomedicines Article The Micro Vascular Plug(®) (MVP, Medtronic) is a mechanical embolic agent available in small sizes that allows for distal embolisation. The objective of this retrospective observational single-centre study was to assess MVP embolisation procedures performed at a university hospital. The 33 patients who underwent MVP embolisation in 2021 were included (mean age, 64; 24 males and 9 females). The primary endpoint was technical success, which was defined as a full first-attempt occlusion with one or more MVPs, as documented on the end-of-procedure angiogram. In all patients, 51 MVPs were used overall, with other embolic agents in 23 of the 33 cases (usually coils and/or glue); 22 of the 33 procedures were emergent for bleeding and 11 were planned for other indications. Of the three technical failures, two were due to an angled target artery configuration precluding microcatheterisation and one to failure of the device to release from its wire. The technical success rate was thus 90.9%. No patient experienced MVP migration or other major complications. Five patients had recurrent clinical symptoms; in four cases, the cause was collateral development, and in one case, the cause was incomplete initial embolisation. No instances of recanalisation were documented during the short follow-up of 12 months, for a 100% secondary clinical success rate. At our tertiary-level centre, the MVP was both effective and safe for peripheral applications. Interventional radiologists should be conversant with the techniques and indications of MVP embolisation. MDPI 2023-08-02 /pmc/articles/PMC10452264/ /pubmed/37626671 http://dx.doi.org/10.3390/biomedicines11082172 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Mailli, Rémy Chevallier, Olivier Mazit, Amin Malakhia, Alexandre Falvo, Nicolas Loffroy, Romaric Embolisation Using Microvascular Plugs for Peripheral Applications: Technical Results and Mid-Term Outcomes |
title | Embolisation Using Microvascular Plugs for Peripheral Applications: Technical Results and Mid-Term Outcomes |
title_full | Embolisation Using Microvascular Plugs for Peripheral Applications: Technical Results and Mid-Term Outcomes |
title_fullStr | Embolisation Using Microvascular Plugs for Peripheral Applications: Technical Results and Mid-Term Outcomes |
title_full_unstemmed | Embolisation Using Microvascular Plugs for Peripheral Applications: Technical Results and Mid-Term Outcomes |
title_short | Embolisation Using Microvascular Plugs for Peripheral Applications: Technical Results and Mid-Term Outcomes |
title_sort | embolisation using microvascular plugs for peripheral applications: technical results and mid-term outcomes |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10452264/ https://www.ncbi.nlm.nih.gov/pubmed/37626671 http://dx.doi.org/10.3390/biomedicines11082172 |
work_keys_str_mv | AT mailliremy embolisationusingmicrovascularplugsforperipheralapplicationstechnicalresultsandmidtermoutcomes AT chevallierolivier embolisationusingmicrovascularplugsforperipheralapplicationstechnicalresultsandmidtermoutcomes AT mazitamin embolisationusingmicrovascularplugsforperipheralapplicationstechnicalresultsandmidtermoutcomes AT malakhiaalexandre embolisationusingmicrovascularplugsforperipheralapplicationstechnicalresultsandmidtermoutcomes AT falvonicolas embolisationusingmicrovascularplugsforperipheralapplicationstechnicalresultsandmidtermoutcomes AT loffroyromaric embolisationusingmicrovascularplugsforperipheralapplicationstechnicalresultsandmidtermoutcomes |